Stay updated on Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.

Latest updates to the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedMinor wording updates: the additions clarify that publications are automatically filled from PubMed and note Revision: v3.3.2, while the deletions indicate PubMed-derived data and list Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the lapse-in-government-funding operating-status notice from the page. This change does not affect the study details, eligibility criteria, or reported outcomes.SummaryDifference0.4%

- Check43 days agoChange DetectedNo significant content changes were detected on the Study Details page for NCT02777385. The screenshots show only minor UI/layout differences that do not affect the information presented.SummaryDifference0.4%

- Check72 days agoChange Detected- Added a government funding notice with operational details for the NIH Clinical Center and where to check status (high importance). - Updated version from v3.1.0 to v3.2.0 (medium importance). - Removed old version tag v3.1.0 (paired with the new v3.2.0 update).SummaryDifference2%

- Check79 days agoChange DetectedUpdated version to v3.1.0 and removed a specific resource (Head and neck squamous cell carcinoma) from CRDI resources. If these changes are not part of core page content, note that this is a minor update with a targeted resource removal and a new version tag.SummaryDifference0.4%

- Check93 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.